# Hyrimoz · 40 mg · Roztwór do wstrzykiwań we wstrzykiwaczu · wstrzykiwacz 0,8 1 ml



## Poland

- **URPL** — [pl.dose-10060.org](https://pl.dose-10060.org)

## Codes

- **rpl-pack-id** — `129227`
- **eu-number** — `EU/1/18/1286/004`

## Status

- **read** — 2026-11-15T02:02:49Z

## Holder

- Sandoz GmbH

## Proof

Record pl:presentation:129227 version 1, signed ES256 under dosidal-record-1.9dbf5d53.

## Related records in other markets

- [Hyrimoz 40 mg](https://dosidal.ai/pack/be/533582-01) — BE — same product (EU central number)
- [HYRIMOZ](https://dosidal.ai/pack/cz/0223023) — CZ — same product (EU central number)
- [Hyrimoz](https://dosidal.ai/pack/eu/EU-1-18-1286-004) — EU — same product (EU central number)
- [HYRIMOZ 40 MG OLDATOS INJEKCIÓ ELŐRETÖLTÖTT INJEKCIÓS TOLLBAN](https://dosidal.ai/pack/hu/210845438) — HU — same product (EU central number)
- [Hyrimoz 40 mg injekčný roztok v naplnenom pere](https://dosidal.ai/pack/sk/8599C) — SK — same product (EU central number)

A link shows how two records are related. It does not say one product can be used in place of another.

## Contact

Contact: the form at the bottom of https://dosidal.ai/#contact

---
Dosidal is a product record. It identifies a medicine and its regulatory status. It does not advise on use.
Artificial intelligence makes mistakes. Dosidal is an information source, not a recommendation. Read the regulator.
Dosidal is operated by Dosidal AI Corp. Office: 6687 Nelson Avenue, Suite 304, West Vancouver, BC V7W 2B2, Canada.
© 2027 Dosidal AI Corp.
Dosidal · dosidal.ai · Surface 1.0 (2026-11-16)
